Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
European Journal of Medicinal Chemistry|November 19, 2013
Structural determinants for ERK5 (MAPK7) and leucine rich repeat kinase 2 activities of benzo[e]pyrimido-[5,4-b]diazepine-6(11H)-onesXianming Deng, Jonathan M Elkins, Jinwei Zhang, et al.
Cell Death & Disease|September 18, 2020
The antitumour drug ABTL0812 impairs neuroblastoma growth through endoplasmic reticulum stress-mediated autophagy and apoptosisLaia París-Coderch, Aroa Soriano, Carlos Jiménez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2015
The New Antitumor Drug ABTL0812 Inhibits the Akt/mTORC1 Axis by Upregulating Tribbles-3 PseudokinaseTatiana Erazo, Mar Lorente, Anna López-Plana, et al.
NPJ Breast Cancer|January 29, 2026
Monitoring of circulating tumor DNA in patients with stage II-III breast cancer treated with neoadjuvant chemotherapyLuc Cabel, Julia Ah-Reum An, Hong-Kyu Kim, et al.
Autophagy|May 14, 2020
The anti-cancer drug ABTL0812 induces ER stress-mediated cytotoxic autophagy by increasing dihydroceramide levels in cancer cellsPau Muñoz-Guardiola, Josefina Casas, Elisabet Megías-Roda, et al.
Nature Communications|September 27, 2022
TP53 mutations and RNA-binding protein MUSASHI-2 drive resistance to PRMT5-targeted therapy in B-cell lymphomaTatiana Erazo, Chiara M Evans, Daniel Zakheim, et al.
International Journal of Cancer|January 17, 2020
The novel proautophagy anticancer drug ABTL0812 potentiates chemotherapy in adenocarcinoma and squamous nonsmall cell lung cancerAnna López-Plana, Patricia Fernández-Nogueira, Pau Muñoz-Guardiola, et al.
ACS Chemical Biology|August 14, 2018
Structural and Atropisomeric Factors Governing the Selectivity of Pyrimido-benzodiazipinones as Inhibitors of Kinases and BromodomainsJinhua Wang, Tatiana Erazo, Fleur M Ferguson, et al.
European Journal of Cancer (Oxford, England : 1990)|August 16, 2024
Optimal systemic treatment and real-world clinical application of ctDNA in patients with metastatic HER2-mutant lung cancerSi-Yang Liu, Tatiana Erazo, Justin Jee, et al.
Pageof 2